|
|
|
|
Though the biotech scene in Poland is relatively new, it has much to offer drug developers looking for innovative approaches, affordable costs, and rapid timelines. Thanks to support from the EU and ongoing collaboration between key stakeholders, Poland has built an infrastructure with ample resources to support global biomanufacturing.
|
|
|
|
|
Transparency and communication are essential to the success of a manufacturing partnership. If a CDMO is unwilling to have frank conversations during the proposal phase, that’s likely a red flag. The right partner’s team will help you make educated choices while ensuring quality, reasonable costs, and timeline efficiency.
|
|
|
|
|
Several measures are recommended to prevent Mycoplasma contamination in bioprocessing operations. Learn how following strict laboratory practices and conducting routine testing for Mycoplasma contamination using nucleic acid-based assays can help ensure the production of safe and high-quality biopharmaceutical products.
|
|
|
|
|
|
Capacity Update May 2024: Large Molecule Development
|
Review our installations in upstream development, downstream development, and fill & finish. Our state-of-the-art EU-GMP certified facility is staffed by a team of 250 professionals and, as of 2023, is focused solely on providing CDMO services to its clients. Capacity is now available and our team is excited to engage in new projects.
|
|
• Request Information
|
|
|
|
|
|
|
|
